Skip to main content

MW 318.24 g/mol, Purity >97%. Directly inhibits MEK, JAK1, Akt and MKK4 kinase activity. Able to inhibit cytochrome P450 3A4 and 2C9 (IC50 = 7.81 and 13.5 μM, respectively).

.

Be the first to review this product! Submit a review

Images

Chemical Structure - Myricetin, irreversible TrxR inhibitor (AB120721), expandable thumbnail
  • Functional Studies - Myricetin, irreversible TrxR inhibitor (AB120721), expandable thumbnail

Key facts

CAS number
529-44-2
Purity
> 97%
Form
Solid
Molecular weight
318.24 g/mol
Molecular formula
C15H10O8
Nature
Synthetic

Recommended products

MW 318.24 g/mol, Purity >97%. Directly inhibits MEK, JAK1, Akt and MKK4 kinase activity. Able to inhibit cytochrome P450 3A4 and 2C9 (IC50 = 7.81 and 13.5 μM, respectively).

.

Key facts

Purity
> 97%
Solubility

Soluble in DMSO to 100 mM.

Soluble in ethanol to 50 mM.

Biological description

Directly inhibits MEK, JAK1, Akt and MKK4 kinase activity. Able to inhibit cytochrome P450 3A4 and 2C9 (IC50 = 7.81 and 13.5 μM, respectively).

IUPAC name
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - Myricetin, irreversible TrxR inhibitor (ab120721), expandable thumbnail

    Chemical Structure - Myricetin, irreversible TrxR inhibitor (ab120721)

    2D chemical structure image of ab120721, Myricetin, irreversible TrxR inhibitor

  • Functional Studies - Myricetin, irreversible TrxR inhibitor (ab120721), expandable thumbnail

    Functional Studies - Myricetin, irreversible TrxR inhibitor (ab120721)

    PC 12 cells were incubated at 37°C for 30 minutes with vehicle control (0 μM) and different concentrations of myricetin (ab120721). Increased expression of CaMKII (phospho T286) (Anti-CaMKII (phospho T286) antibody ab32678) in PC 12 cells correlates with an increase in myricetin concentration, as described in literature.

    Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with ab32678at 1/500 dilution and Anti-CaMKII antibody [EP1829Y] ab52476 at 1/500 dilution overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/10000 dilution and visualised using ECL development solution.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com